Compare L3Harris Technologies Inc (LHX) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
L3Harris Technologies Inc vs NeoGenomics Inc. Common Stock — how do they compare? L3Harris Technologies Inc trades at $239.35 (market cap $44.23B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: L3Harris Technologies Inc is far larger — about 20.4× NeoGenomics Inc. Common Stock's market cap, and L3Harris Technologies Inc pays a 2.11% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold L3Harris Technologies Inc for 56 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| LHX | NEO | |
|---|---|---|
Market Cap | $44.23B | $2.17B |
Volume | 2,425,901 | 1,615,943 |
Sector | Industrials | Health |
52-Week High | $378.48 | $19.91 |
52-Week Low | $233.63 | $7.19 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $54.67B | $2.47B |
Dividend Yield | 2.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LHX trades at $234.72, down 1.48% today, amid a bearish technical signal despite strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent contract wins totaling over $10 billion for THAAD and PAC-3 MSE propulsion systems highlight growth potential, though multiple law firm investigations create investor uncertainty. Revenue has grown steadily from $17.1B in 2022 to $21.9B in 2025, with profit margins improving to 7.34%.
Analysts remain bullish with a $340 consensus price target (45% upside), but technical indicators show selling pressure. Key risks include ongoing legal investigations and execution challenges on major defense contracts. The stock offers value with a P/E of 23.71 below industry averages, supported by strong cash flow generation and dividend payments.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About L3Harris Technologies Inc
L3Harris Technologies was created in 2019 from the merger of L3 Technologies and Harris, two defense contractors that provide products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) market. The firm also has smaller operations serving the civil government, particularly the Federal Aviation Administration's communication infrastructure, and produces various avionics for defense and commercial aviation.
Read more on LHX →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
